Luke Sergott

Stock Analyst at Barclays

(2.29)
# 1,443
Out of 4,496 analysts
185
Total ratings
42.86%
Success rate
-3.48%
Average return

18 Stocks

Waters
Jun 28, 2024
Maintains: Underweight
Price Target: $295$275
Current: $316.73
Upside: -13.18%
Twist Bioscience
Jun 28, 2024
Maintains: Overweight
Price Target: $45$60
Current: $58.66
Upside: +2.28%
Thermo Fisher
Jun 28, 2024
Maintains: Equal-Weight
Price Target: $615$600
Current: $555.42
Upside: +8.03%
Revvity
Jun 28, 2024
Maintains: Equal-Weight
Price Target: $116$115
Current: $113.12
Upside: +1.66%
IQVIA Holdings
Jun 28, 2024
Maintains: Overweight
Price Target: $275$255
Current: $232.97
Upside: +9.46%
Certara
Jun 28, 2024
Maintains: Equal-Weight
Price Target: $18$16
Current: $16.50
Upside: -3.03%
Catalent
Jun 28, 2024
Maintains: Equal-Weight
Price Target: $47$63
Current: $57.85
Upside: +8.90%
Avantor
Jun 28, 2024
Maintains: Overweight
Price Target: $28$25
Current: $21.53
Upside: +16.12%
10x Genomics
Jun 28, 2024
Maintains: Overweight
Price Target: $36$24
Current: $20.00
Upside: +20.00%
Charles River Laboratories International
Jun 28, 2024
Initiates: Equal-Weight
Price Target: $230
Current: $227.31
Upside: +1.18%
Agilent Technologies
May 31, 2024
Maintains: Underweight
Price Target: $135$125
Current: $136.06
Upside: -8.13%
Pacific Biosciences of California
May 10, 2024
Maintains: Equal-Weight
Price Target: $3$2
Current: $2.18
Upside: -8.05%
Danaher
Apr 24, 2024
Maintains: Equal-Weight
Price Target: $260$270
Current: $252.14
Upside: +7.08%
Illumina
Apr 10, 2024
Maintains: Underweight
Price Target: $85$100
Current: $125.23
Upside: -20.15%
Sotera Health Company
Apr 10, 2024
Maintains: Overweight
Price Target: $19$14
Current: $12.90
Upside: +8.53%
ICON PLC
Feb 23, 2024
Maintains: Overweight
Price Target: $325$355
Current: $346.20
Upside: +2.54%
Fortrea Holdings
Jan 25, 2024
Maintains: Overweight
Price Target: $38$35
Current: $27.92
Upside: +25.36%
Centogene
Apr 24, 2020
Downgrades: In-Line
Price Target: n/a
Current: $0.53
Upside: -